SCHEMBL7687764

SCHEMBL7687764

N#CC1(c2cncc(Cl)c2)CC2CC(Oc3ccc(C=S)cc3)C(C1)N2Cc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 2/20 0.35
KCNH2 Q12809 2/20 0.35
HRH3 Q9Y5N1 1/20 0.34
RET P07949 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691750 0.86 CHRNB2 (0.32)
SCHEMBL7688677 0.80 KCNH2 (0.35) OPRK1KCNH2RET
SCHEMBL7684150 0.79 OPRK1 (0.33) OPRK1KCNH2RET
SCHEMBL7685772 0.79 KCNH2 (0.37) OPRK1KCNH2RET
SCHEMBL7221508 0.77 OPRL1 (0.43) OPRK1KCNH2RET
SCHEMBL7681999 0.76
SCHEMBL7685312 0.75 OPRL1 (0.39) OPRK1KCNH2RET
SCHEMBL8125172 0.73 HRH3 (0.37) OPRK1KCNH2HRH3
SCHEMBL6615999 0.73 OPRM1 (0.39) OPRK1KCNH2
SCHEMBL6616496 0.72 OPRK1 (0.42) OPRK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020061913-A1 Bicyclic amine derivatives SYNGENTA LIMITED (GB) 2002-05-23 US disclosed
US-6294545-B1 INSECTICIDES SYNGENTA LIMITED (GB) 2001-09-25 US disclosed
US-6291474-B1 COMBATING AND CONTROLLING INSECT, ACARINE OR NEMATODE PESTS ZENECA LIMITED (GB) 2001-09-18 US disclosed
US-6177442-B1 INSECTICIDES; PESTICIDES; MITICIDES; NEMATOCIDES ZENECA LIMITED (GB) 2001-01-23 US disclosed
US-5968947-A INSECTICIDES, ACARICIDES, NEMATOCIDES ZENECA LIMITED (GB) 1999-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061913-A1 Bicyclic amine derivatives ADRA1D, TAAR1, ADRA1A OPRK1 523/4885KCNH2 1046/4885HRH3 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.